CIK 0001326110 · Large accelerated filer
ImmunityBio, Inc.
Sign in to watch- Ticker
- IBRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 431979754
- Phone
- (844) 696-5235
- Business address
- 3530 JOHN HOPKINS COURT, SAN DIEGO, CA, 92121
- Former names
- NantKwest, Inc., Conkwest, Inc., ZelleRx Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,119,848
- in 2 filings, $1.1M under 10b5-1 plans
Net −$1,119,848. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-15 | LAUER REGAN J Chief Accounting Officer | Option exercise · Restricted Stock Units | −21,031 | 0 | ||
| 2024-12-10 | SOON-SHIONG PATRICK See remarks | Conversion | +103,710,088 | $1.94 | $200.7M | 232,937,105 |
| 2024-12-10 | SOON-SHIONG PATRICK See remarks | Conversion | +13,475,172 | $2.28 | $30.7M | 246,412,277 |
| 2024-12-10 | SOON-SHIONG PATRICK See remarks | Conversion · Convertible Promissory Note | −0 | |||
| 2024-12-10 | SOON-SHIONG PATRICK See remarks | Conversion · Convertible Promissory Note | −0 | |||
| 2024-12-10 | SOON-SHIONG PATRICK See remarks | Other disposition · Amended and Restated Promissory Note | −0 | |||
| 2024-12-10 | SOON-SHIONG PATRICK See remarks | Other acquisition · Second Amended and Restated Convertible Promissory Note | +0 | $505,000,000.00 | $0 | |
| 2024-06-11 | Brennan John Owen Director | Grant or award · Stock Option (right to buy) | +77,633 | 77,633 | ||
| 2024-06-11 | Clark Wesley Director | Grant or award · Stock Option (right to buy) | +77,633 | 77,633 | ||
| 2024-06-11 | Cohen Cheryl Director | Grant or award · Stock Option (right to buy) | +77,633 | 77,633 | ||
| 2024-06-11 | Selecky Christobel Director | Grant or award · Stock Option (right to buy) | +77,633 | 77,633 | ||
| 2024-06-11 | BLASZYK MICHAEL D Director | Grant or award · Stock Option (right to buy) | +77,633 | 77,633 | ||
| 2024-06-11 | MAXWELL LINDA Director | Grant or award · Stock Option (right to buy) | +77,633 | 77,633 | ||
| 2024-02-22 | Simon Barry J. Director | Grant or award · Restricted Stock Units | +45,731 | 45,731 | ||
| 2024-02-22 | Simon Barry J. Director | Grant or award · Stock Option (right to buy) | +159,146 | 159,146 | ||
| 2024-02-22 | LAUER REGAN J Chief Accounting Officer | Grant or award · Restricted Stock Units | +12,195 | 12,195 | ||
| 2024-02-22 | LAUER REGAN J Chief Accounting Officer | Grant or award · Stock Option (right to buy) | +42,439 | 42,439 | ||
| 2024-02-22 | Sachs David C. Chief Financial Officer | Grant or award · Restricted Stock Units | +121,951 | 121,951 | ||
| 2024-02-22 | Sachs David C. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +424,390 | 424,390 | ||
| 2024-02-22 | Adcock Richard CEO & President | Grant or award · Restricted Stock Units | +457,317 | 457,317 |
Page 7 of 12 · 226 trades